Expanding on its relaunch in Vietnam and launch in Taiwan, Kirin Holdings is introducing Kirin Immuse Yoghurt Flavour in Singapore on 20 July 2026. This marks the company’s first entry into the Singapore market with a beverage featuring L. lactis Plasma, developed by Kirin to help consumers easily incorporate healthy habits into their daily lives. Each serving contains 100 billion L. lactis Plasma, aligning with local health awareness and lifestyle trends.
The Singapore launch is positioned as the first step in the full‑scale development of Kirin’s L. lactis Plasma business in Southeast Asia. In collaboration with Fullerton Health*, sales and communication will be carried out using the company’s service platform. Distribution will be expanded sequentially through drugstores, supermarkets, convenience stores, and e‑commerce channels, ensuring broad accessibility for health‑conscious consumers.
Initially, sales will begin through the Fullerton Health Marketplace, creating direct touchpoints with health‑aware individuals. Looking ahead, Kirin plans to leverage Fullerton Health’s membership base and corporate client network to expand reach. This unique partnership ensures that accurate information about L. lactis Plasma is delivered to consumers, while building credibility through healthcare‑driven communication.
*Fullerton Health is a leading integrated healthcare solutions provider. Founded in 2010, the Group operates across the Asia‑Pacific region with nearly 500 clinics and a network of more than 18,000 providers. Its services span the entire care journey — from managed care and network management to primary care, diagnostics, specialty care, and ancillary services.
